Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock Common Stock - Class A	Common Stock Common Stock - Class B	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balances, at beginning of the period (in shares) at Jan. 31, 2020		11,206	70,000
Balances, at beginning of the period at Jan. 31, 2020	$ 666,880	$ 112	$ 700	$ 896,983	$ (207,929)	$ (3,090)	$ (19,896)
Statement of Shareholders' Equity
Net loss	(12,371)				(12,371)
Other comprehensive income (loss)	(73)					(73)
Vesting of restricted stock units (in shares)		993
Vesting of restricted stock units	0	$ 9		(9)
Grant of restricted stock awards (in shares)		455
Grant of restricted stock awards	0	$ 5		(5)
Common stock withheld as payment of taxes and cost for equity awards (in shares)		(418)
Common stock withheld as payment of taxes and cost for equity awards	(4,962)	$ (4)		(4,958)
Stock-based compensation	17,675			17,675
Balances, at end of the period (in shares) at Oct. 30, 2020		12,236	70,000
Balances, at end of the period at Oct. 30, 2020	667,149	$ 122	$ 700	909,686	(220,300)	(3,163)	(19,896)
Balances, at beginning of the period (in shares) at Jul. 31, 2020		12,186	70,000
Balances, at beginning of the period at Jul. 31, 2020	665,567	$ 122	$ 700	903,909	(216,692)	(2,576)	(19,896)
Statement of Shareholders' Equity
Net loss	(3,608)				(3,608)
Other comprehensive income (loss)	(587)					(587)
Vesting of restricted stock units (in shares)		75
Vesting of restricted stock units	0	$ 0		0
Common stock withheld as payment of taxes and cost for equity awards (in shares)		(25)
Common stock withheld as payment of taxes and cost for equity awards	(304)	$ 0		(304)
Stock-based compensation	6,081			6,081
Balances, at end of the period (in shares) at Oct. 30, 2020		12,236	70,000
Balances, at end of the period at Oct. 30, 2020	667,149	$ 122	$ 700	909,686	(220,300)	(3,163)	(19,896)
Balances, at beginning of the period (in shares) at Jan. 29, 2021		12,450	70,000
Balances, at beginning of the period at Jan. 29, 2021	667,781	$ 124	$ 700	917,344	(229,831)	(660)	(19,896)
Statement of Shareholders' Equity
Net loss	(31,016)				(31,016)
Other comprehensive income (loss)	(535)					(535)
Vesting of restricted stock units (in shares)		1,380
Vesting of restricted stock units	0	$ 14		(14)
Exercise of stock options (in shares)		1,417
Exercise of stock options	4,134	$ 14		4,120
Grant of restricted stock awards (in shares)		485
Grant of restricted stock awards	0	$ 5		(5)
Common stock withheld as payment of taxes and cost for equity awards (in shares)		(1,530)
Common stock withheld as payment of taxes and cost for equity awards	(11,710)	$ (15)		(11,695)
Stock-based compensation	23,677			23,677
Balances, at end of the period (in shares) at Oct. 29, 2021		14,202	70,000
Balances, at end of the period at Oct. 29, 2021	652,331	$ 142	$ 700	933,427	(260,847)	(1,195)	(19,896)
Balances, at beginning of the period (in shares) at Jul. 30, 2021		14,092	70,000
Balances, at beginning of the period at Jul. 30, 2021	657,518	$ 141	$ 700	925,131	(247,984)	(574)	(19,896)
Statement of Shareholders' Equity
Net loss	(12,863)				(12,863)
Other comprehensive income (loss)	(621)					(621)
Vesting of restricted stock units (in shares)		183
Vesting of restricted stock units	0	$ 2		(2)
Common stock withheld as payment of taxes and cost for equity awards (in shares)		(73)
Common stock withheld as payment of taxes and cost for equity awards	(1,765)	$ (1)		(1,764)
Stock-based compensation	10,062			10,062
Balances, at end of the period (in shares) at Oct. 29, 2021		14,202	70,000
Balances, at end of the period at Oct. 29, 2021	$ 652,331	$ 142	$ 700	$ 933,427	$ (260,847)	$ (1,195)	$ (19,896)